Literature DB >> 19646966

Expression and functional activities of selected sulfotransferase isoforms in BeWo cells and primary cytotrophoblast cells.

Pallabi Mitra1, Kenneth L Audus.   

Abstract

Several cytosolic sulfotransferase enzyme isoforms are functional in placenta but there is limited information available on the utility of cultured trophoblast cells for studying sulfation. The trophoblast cell layer constitutes the rate-determining barrier for trans-placental transfer. The objective of this work was to examine the mRNA expression and enzyme activities of four sulfotransferase isoforms reported to be functional in human placenta (SULT1A1, SULT1A3, SULT1E1, and SULT2A1) in primary cytotrophoblast cells and the trophoblast-like BeWo cell line. Reverse transcription polymerase chain reaction (RT-PCR) was performed to determine mRNA expression. Enzyme activities were assessed using the following substrates: 4-nitrophenol for SULT1A1, dopamine for SULT1A3, 17beta-estradiol for SULT1E1, and dehydroepiandrosterone for SULT2A1. For 4-nitrophenol and dopamine sulfation, apparent K(m) values, response to inhibitors (2,6-dichloro-4-nitrophenol and sodium chloride), and thermal stability profiles indicated that 4-nitrophenol and dopamine sulfation in BeWo cells were being mediated by SULT1A1 and SULT1A3, respectively. SULT1A1 and SULT1A3 were also functional in the cytotrophoblast cells. Both at the protein and at the mRNA levels, SULT1A1 was more abundant in BeWo cells in comparison to the primary cytotrophoblast cells. SULT1E1 and SULT2A1 mRNA were not detected in the cytotrophoblasts. SULT1E1 mRNA was weakly expressed in BeWo but there was negligible functional activity. Although SULT2A1 mRNA was abundantly expressed in BeWo, Western blot and enzyme activities revealed that the protein is not expressed in BeWo cells. The results suggest that the BeWo cells and the cytotrophoblast cells can be used to examine the roles of SULT1A1 and SULT1A3 in placental metabolism.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19646966      PMCID: PMC2767256          DOI: 10.1016/j.bcp.2009.07.013

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  57 in total

Review 1.  Sulfonation and molecular action.

Authors:  Charles A Strott
Journal:  Endocr Rev       Date:  2002-10       Impact factor: 19.871

2.  Structure of a human carcinogen-converting enzyme, SULT1A1. Structural and kinetic implications of substrate inhibition.

Authors:  Niranjali U Gamage; Ronald G Duggleby; Amanda C Barnett; Michael Tresillian; Catherine F Latham; Nancy E Liyou; Michael E McManus; Jennifer L Martin
Journal:  J Biol Chem       Date:  2002-12-05       Impact factor: 5.157

3.  Systemic distribution of steroid sulfatase and estrogen sulfotransferase in human adult and fetal tissues.

Authors:  Yasuhiro Miki; Taisuke Nakata; Takashi Suzuki; Andrew David Darnel; Takuya Moriya; Chika Kaneko; Kumiko Hidaka; Yukimasa Shiotsu; Hideaki Kusaka; Hironobu Sasano
Journal:  J Clin Endocrinol Metab       Date:  2002-12       Impact factor: 5.958

4.  The presence of inducible cytochrome P450 types 1A1 and 1A2 in the BeWo cell line.

Authors:  M L Avery; C E Meek; K L Audus
Journal:  Placenta       Date:  2003-01       Impact factor: 3.481

5.  Differential expression of sulfotransferase enzymes involved in thyroid hormone metabolism during human placental development.

Authors:  E L Stanley; R Hume; T J Visser; M W Coughtrie
Journal:  J Clin Endocrinol Metab       Date:  2001-12       Impact factor: 5.958

6.  Human gastrointestinal sulfotransferases: identification and distribution.

Authors:  Guangping Chen; Daqing Zhang; Nin Jing; Shuhua Yin; Charles N Falany; Anna Radominska-Pandya
Journal:  Toxicol Appl Pharmacol       Date:  2003-03-15       Impact factor: 4.219

Review 7.  Efflux transporters of the human placenta.

Authors:  Amber M Young; Courtni E Allen; Kenneth L Audus
Journal:  Adv Drug Deliv Rev       Date:  2003-01-21       Impact factor: 15.470

8.  Phenol sulfotransferase 1A1 activity in human liver: kinetic properties, interindividual variation and re-evaluation of the suitability of 4-nitrophenol as a probe substrate.

Authors:  Catherine A Tabrett; Michael W H Coughtrie
Journal:  Biochem Pharmacol       Date:  2003-12-01       Impact factor: 5.858

9.  Conjugation of catechols by recombinant human sulfotransferases, UDP-glucuronosyltransferases, and soluble catechol O-methyltransferase: structure-conjugation relationships and predictive models.

Authors:  Jyrki Taskinen; Brian T Ethell; Pia Pihlavisto; Alan M Hood; Brian Burchell; Michael W H Coughtrie
Journal:  Drug Metab Dispos       Date:  2003-09       Impact factor: 3.922

10.  Steroid sulfatase and estrogen sulfotransferase in normal human tissue and breast carcinoma.

Authors:  Takashi Suzuki; Yasuhiro Miki; Taisuke Nakata; Yukimasa Shiotsu; Shiro Akinaga; Kengo Inoue; Takanori Ishida; Michio Kimura; Takuya Moriya; Hironobu Sasano
Journal:  J Steroid Biochem Mol Biol       Date:  2003-09       Impact factor: 4.292

View more
  3 in total

1.  Kinetics of silica nanoparticles in the human placenta.

Authors:  Marie Sønnegaard Poulsen; Tina Mose; Lisa Leth Maroun; Line Mathiesen; Lisbeth Ehlert Knudsen; Erik Rytting
Journal:  Nanotoxicology       Date:  2013-07-01       Impact factor: 5.913

2.  MRP isoforms and BCRP mediate sulfate conjugate efflux out of BeWo cells.

Authors:  Pallabi Mitra; Kenneth L Audus
Journal:  Int J Pharm       Date:  2009-09-25       Impact factor: 5.875

3.  Disruption of thyroid hormone sulfotransferase activity by brominated flame retardant chemicals in the human choriocarcinoma placenta cell line, BeWo.

Authors:  Christopher P Leonetti; Craig M Butt; Heather M Stapleton
Journal:  Chemosphere       Date:  2017-12-28       Impact factor: 7.086

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.